Argenx
ARGX
#421
Rank
S$74.71 B
Marketcap
S$1,188
Share price
3.63%
Change (1 day)
4.96%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): S-$5.62

According to Argenx 's latest financial reports the company's current EPS (TTM) is S$28.65. In 2022 the company made an earnings per share (EPS) of S-$16.81.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$5.62-66.55%
2022S-$16.81